Corium
Manufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
11 Farnsworth St Fl 4, Boston, Massachus...Phone Number
(800) 910-8432Website
www.corium.comRevenue
$148.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
4
1
1
1
1
About Corium
Corium, LLC, is a biopharmaceutical company that is leading the development and commercialization of neuroscience therapies that provide physicians with innovative treatment options for patients, their families, and their caregivers. Corium is commercializing two U.S. FDA approved products, ADLARITY and AZSTARYS, in the U.S., and has licensed each for development and commercialization in certain territories outside the U.S.Explore more
Corium Org Chart
LD
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Corium your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Corium
Funding: Get notified immidiatlly once Corium has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Corium is spiking on competitors!
Product Launch: Get notified when Corium launches new products
Corium, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Corium had a recent Job posting/layoffs
Check if Corium has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Corium recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Corium as Masked Content
Find more new buyers
Compare Similar Companies to Corium
Compare insights from companies similar to Corium, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Corium is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Corium is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Corium.
Corium financials insights
Gather financial insights about Corium, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$52M
2018
Private Equity
$504M
Corium Tech Stack
A closer look at the technologies used by Corium
Most Recent Scoops
Open Position
Hiring Plans
Corium has more open roles in Sales than it has had at any time in the past 6 months with an increased focus that include Sales Optimization, Solution Selling, and Sales Territory Management.
Hiring Plans
New Hire
Executive Move
Corium has announced that Logan Derck has joined the organization as Chief Financial Officer.
Executive Moves, New Hire
Hiring Plans
Corium has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Hiring Plans
Corium News & Media
Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY® in Multiple Markets Across Asia
BOSTON & TAIPEI, Taiwan--(BUSINESS WIRE)--Corium, LLC (“Corium”), a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies, and Lotus Pharmaceutical (1795:TT; “Lotus”), a multinational pharmaceutical company, announced that the companies have entered into an exclusive Collaboration and License Agreement for ADLARITY® (donepezil transdermal system), an innovative Alzheimer’s dementia treatment, in ten markets across Asia. ADLARITYJournal Frontiers in Psychiatry Publishes Analysis of Open Label Safety Study Showing Improvements in Sleep Habits for Children With ADHD After Treatment With AZSTARYS® (serdexmethylphenidate and dexmethylphenidate)
Sleep domain score improvements were statistically significant and observed throughout the twelve-month study BOSTON, June 26, 2023 /PRNewswire/ -- Corium, LLC, a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS)...Corium's Novel ADHD Medication AZSTARYS® (Serdexmethylphenidate and Dexmethylphenidate) Had No Clinically Significant Impact on Children's Weight and Height Growth Rate
New analysis from long-term study published in Journal of Child and Adolescent Psychopharmacology Reinforces prior data demonstrating AZSTARYS, first and only medicine of its kind, is effective and safe BOSTON , May 22, 2023 /PRNewswire/ -- Corium, LLC, a commercial-stage...Corium to Report Positive Data on ADHD Medication AZSTARYS® (serdexmethylphenidate and dexmethylphenidate) at 2023 American Neuropsychiatric Association Annual Meeting and at 2023 National Association of Pediatric Nurse Practitioners Conference
AZSTARYS data includes durable ADHD symptom improvement, dose optimization effects, improved sleep impact, and real-world claims analysis AZSTARYS is the first and only treatment for ADHD containing an immediate release component and the prodrug serdexmethylphenidate, together providing...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Corium
Sign Up For FreeTo access detailed company insights
Corium, LLC, is a biopharmaceutical company that is leading the development and commercialization of neuroscience therapies that provide physicians with innovative treatment options for patients, their families, and their caregivers. Corium is commercializing two U.S. FDA approved products, ADLARITY and AZSTARYS, in the U.S., and has licensed each... Read More
